Literature DB >> 24714290

Fish-mouth appearance of the ampulla of Vater.

Iosif Beintaris1, Demetrios Polymeros1, Silvia Krivan2, Konstantinos Triantafyllou1.   

Abstract

Entities:  

Year:  2013        PMID: 24714290      PMCID: PMC3959499     

Source DB:  PubMed          Journal:  Ann Gastroenterol        ISSN: 1108-7471


× No keyword cloud information.
Cystic tumors of the pancreas account for less than 10% of pancreatic neoplasms. Intraductal papillary mucinous carcinomas (IPMNs) account for 21-33% of these tumors. IPMNs represent papillary neoplasms within the main pancreatic duct and/or side branches showing mucin hypersecretion that often leads to duct dilation and chronic obstructive pancreatitis [1]. A 55-year-old patient presented with a history of epigastric pain beginning 5 years ago. During this period the patient had experienced an episode of acute pancreatitis, shortly after which a computed tomography (CT) of the abdomen revealed a pancreatic pseudocyst. An upper endoscopy using a side view endoscope was performed, revealing a patulous ampulla of Vater with extruding mucus (Fig. 1), the fish-mouth sign, practically pathognomonic for an IPMN.
Figure 1

(A) Endoscopic appearance of the ampulla of Vater, showing the fish-mouth sign (B) The ampulla of Vater is shown, extruding mucus

(A) Endoscopic appearance of the ampulla of Vater, showing the fish-mouth sign (B) The ampulla of Vater is shown, extruding mucus IMPNs represent potentially malignant lesions, occurring equally in both genders. Abdominal pain and weight loss are the most common complaints. A history of recurrent pancreatitis is given by 20% of patients, and acute pancreatitis is found in 25% at presentation. Evaluation involves CT or MRI of the abdomen, endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasonography (EUS). Typically, dilation of the pancreatic duct with or without an associated cystic mass is demonstrated. EUS with FNA (fine needle aspiration) provides important information such as the degree of dysplasia, cell-type, extent of disease and malignant potential. Treatment of IPMNs frequently requires pancreatic B resection, which successfully relieves symptoms and prevents progression to invasive carcinoma. Prognosis after resection of IPMN is excellent, with five-year disease specific survival of 75% or better [2,3].
  2 in total

1.  Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.

Authors:  Roberto Salvia; Carlos Fernández-del Castillo; Claudio Bassi; Sarah P Thayer; Massimo Falconi; William Mantovani; Paolo Pederzoli; Andrew L Warshaw
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

2.  Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome.

Authors:  Michael D'Angelica; Murray F Brennan; Arief A Suriawinata; David Klimstra; Kevin C Conlon
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

  2 in total
  1 in total

1.  The CT fish mouth ampulla sign: a highly specific finding in main duct and mixed intraductal papillary mucinous neoplasms.

Authors:  Ting Ting Zhang; Timothy J Sadler; Siobhan Whitley; Rebecca Brais; Edmund Godfrey
Journal:  Br J Radiol       Date:  2019-08-28       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.